Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Hims & Hers Health, Inc. before investing.

In this article, we go over a few key elements for understanding Hims & Hers Health, Inc.’s stock price such as:

• Hims & Hers Health, Inc.’s current stock price and volume
• Why Hims & Hers Health, Inc.’s stock price changed recently
• Upgrades and downgrades for HIMS from analysts
• HIMS’s stock price momentum as measured by its relative strength

About Hims & Hers Health, Inc. (HIMS)

Before we jump into Hims & Hers Health, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company’s curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Want to learn more about Hims & Hers Health, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Hims & Hers Health, Inc..

Hims & Hers Health, Inc.’s Stock Price as of Market Close

As of April 24, 2025, 12:46 PM, CST, Hims & Hers Health, Inc.’s stock price was $28.570.

Hims & Hers Health, Inc. is up 6.96% from its previous closing price of $26.710.

During the last market session, Hims & Hers Health, Inc.’s stock traded between $26.890 and $28.610. Currently, there are approximately 219.03 million shares outstanding for Hims & Hers Health, Inc..

Hims & Hers Health, Inc.’s price-earnings (P/E) ratio is currently at 50.2, which is high compared to the Health Care Providers & Services industry median of 24.2. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Hims & Hers Health, Inc. Stock Price History

Hims & Hers Health, Inc.’s (HIMS) price is currently down 3.32% so far this month.

During the month of April, Hims & Hers Health, Inc.’s stock price has reached a high of $33.700 and a low of $23.970.

Over the last year, Hims & Hers Health, Inc. has hit prices as high as $72.980 and as low as $11.200. Year to date, Hims & Hers Health, Inc.’s stock is up 18.16%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Hims & Hers Health, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of April 23, 2025,, no analysts have changed their rating of Hims & Hers Health, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Hims & Hers Health, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Hims & Hers Health, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Hims & Hers Health, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Hims & Hers Health, Inc. (HIMS) by visiting AAII Stock Evaluator.

Relative Price Strength of Hims & Hers Health, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 23, 2025, Hims & Hers Health, Inc. has a weighted four-quarter relative price strength of 18.85%, which translates to a Momentum Score of 92 and is considered to be Very Strong.

Want to learn more about how Hims & Hers Health, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Hims & Hers Health, Inc. Stock Price: Bottom Line

As of April 24, 2025, Hims & Hers Health, Inc.’s stock price is $28.570, which is up 6.96% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Hims & Hers Health, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.